A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has spread across the world, prompting the World Health Organization to declare the …

Importance Triple-negative breast cancer (TNBC) classified by transcriptional profiling as
the mesenchymal subtype frequently harbors aberrations in the phosphoinositide 3-kinase (…

Breast cancer is the most common malignant disease in female patients worldwide and can
spread to almost every place in the human body, most frequently metastasizing to lymph …

Long-term studies of immunogenicity of SARS-CoV-2 vaccines in patients with cancer are
needed to inform evidence-based guidelines for booster vaccinations and to tailor sequence …

Both tumors and aging alter the immune landscape of tissues. These interactions may play
an important role in tumor progression among elderly patients and may suggest …

Purpose To determine the significant genomic alterations in patients with metastatic breast
cancer (MBC) and survival outcomes in common genotypes. Patients and Methods High-…

PURPOSE The Standardized Definitions for Efficacy End Points (STEEP) criteria, established
in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant …

Background Ladiratuzumab vedotin (LV) is an investigational anti-LIV-1 antibody-drug
conjugate with a protease-cleavable linker to monomethyl auristatin E (MMAE). LIV-1 is highly …

Purpose of Review To provide an overview of the current management of hormone receptor-positive
(HR +) advanced breast cancer as well as highlight ongoing clinical investigation …

Background Triple‐negative breast cancer (TNBC) is a heterogeneous disease with
subtypes having different “targetable” molecular aberrations. Metaplastic breast cancers (MpBCs) …